Retrovirus budding may constitute a port of entry for drug carriers
- 10 January 1996
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1310 (1) , 53-59
- https://doi.org/10.1016/0167-4889(95)00140-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Inhibition of HIV-1 Replication in Cultured Cells with Antisense Oligonucleotides Encapsulated in ImmunoliposomesAntisense Research and Development, 1993
- Inhibition of the Friend Retrovirus by Antisense Oligonucleotides Encapsulated in Liposomes: Mechanism of ActionPharmaceutical Research, 1993
- Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirusBiochemical and Biophysical Research Communications, 1992
- Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activityNucleic Acids Research, 1992
- Polyalkylcyanoacrylate Nanoparticles as Polymeric Carriers for Antisense OligonucleotidesPharmaceutical Research, 1992
- Specific regulation of gene expression by antisense, sense and antigene nucleic acidsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1990
- Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and propertiesBioconjugate Chemistry, 1990
- Antibody targeted liposomes containing poly(rI) · poly(rC) exert a specific antiviral and toxic effect on cells primed with interferons α/β or γBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Designing antisense oligonucleotides aspharmaceutical agentsTrends in Pharmacological Sciences, 1989
- Small liposomes are better than large liposomes for specific drug delivery in vitroBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983